Bottom line
GDOC vs BHCHX: the short answer
GDOC (Goldman Sachs Future Health Care Equity ETF) and BHCHX (Baron Health Care Fund) share a meaningful slice of their top holdings — about 51% by weight.
GDOC is cheaper at 0.75% vs 0.85% — a difference of $10 a year per $10,000 invested.
Over one year, BHCHX returned +10.3% vs −1.6% for GDOC (reporting dates differ).
Updated Nov 19, 2026
GDOC vs BHCHX side by side
| GDOC | BHCHX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Goldman Sachs | Baron Select |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.75% | 0.85% |
| Annual cost per $10k | $75 | $85 |
| 10-yr cost on $10k (prospectus) | $930 | $1,049 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | −1.6% | +10.3% |
| 5-yr return (annualized) | — | +2.8% |
| 10-yr return (annualized) | — | — |
| Best quarter | +10.7% | — |
| Worst quarter | −13.5% | — |
| Net assets (fund) | $20.1M | $114.1M |
| Number of holdings | 42 | 43 |
| Portfolio turnover | 46% | 74% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
12 of GDOC's top 25 holdings also appear in BHCHX's top 25.
| Holding | GDOC | BHCHX |
|---|---|---|
| Eli Lilly & Company | 13.28% | 13.66% |
| Johnson & Johnson | 8.07% | 5.56% |
| Merck & Company Inc | 5.94% | 2.48% |
| Guardant Health Inc | 5.34% | 2.17% |
| Astrazeneca Plc | 4.84% | 2.49% |
| Thermo Fisher Scientific Inc | 4.52% | 3.91% |
| Argenx Se | 4.07% | 4.23% |
| Intuitive Surgical Inc | 3.90% | 1.74% |
| Edwards Lifesciences Corp | 2.98% | 2.64% |
| Roivant Sciences Ltd | 2.39% | 3.88% |
| Mettler-toledo International Inc | 1.59% | 5.60% |
| Vertex Pharmaceuticals Inc | 1.48% | 2.61% |
Source: SEC Form N-PORT
GDOC top 10
- Eli Lilly & Company — 13.28%
- Johnson & Johnson — 8.07%
- Merck & Company Inc — 5.94%
- Guardant Health Inc — 5.34%
- Astrazeneca Plc — 4.84%
- Thermo Fisher Scientific Inc — 4.52%
- Argenx Se — 4.07%
- Intuitive Surgical Inc — 3.90%
- Boston Scientific Corp — 3.78%
- Hoya Corp — 3.53%
BHCHX top 10
- Eli Lilly & Co — 13.66%
- Mettler-Toledo International Inc — 5.60%
- Johnson & Johnson — 5.56%
- Argenx SE — 4.23%
- Thermo Fisher Scientific Inc — 3.91%
- Roivant Sciences Ltd — 3.88%
- Teva Pharmaceutical Industries Ltd — 3.86%
- Welltower Inc — 3.38%
- UnitedHealth Group Inc — 3.28%
- RadNet Inc — 3.24%
FAQ
What is the difference between GDOC and BHCHX?
Which is cheaper, GDOC or BHCHX?
Should I own both GDOC and BHCHX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.